LONDON — The crowded market for menopause supplements offers more variety than certainty, according to a new analysis of products sold by nine major UK retailers.
University College London researchers examined 201 products, recording their ingredients, doses and monthly costs. Reporting on the study found no ingredient, or even category of ingredient, common across the range. Prices ran from about £1.50 to £95 a month.
Herbs appeared in 80% of products, vitamins in 77% and phytoestrogens in 74%. Fewer than half included both calcium and vitamin D, nutrients recommended for bone health in appropriate patients. Those figures describe what manufacturers sell; they do not establish that every product is ineffective or unsafe.
The central problem is mismatch. Packaging and influencer marketing can imply that a proprietary blend is designed for menopause, even when the individual ingredients have weak, inconsistent or dose-specific evidence. Different products may also use the same herb in quantities that cannot be compared easily.
Black cohosh, a common botanical promoted for hot flushes, illustrates why “natural” is not a safety category. Evidence of benefit is mixed, products vary, and rare liver injury has been reported. Supplements can also interact with prescribed medicines or be unsuitable for people with particular conditions.
Professor Joyce Harper, a senior author and UCL reproductive-science specialist, described a rapidly growing market in which many claims outpace the evidence. The analysis does not justify replacing one blanket message with another. Some women cannot or do not want to use hormone therapy, and symptom management should include individual preferences, medical history and non-drug options.
Regulators could make the market easier to navigate by requiring standardised disclosure of ingredient amounts, evidence behind symptom claims, known interactions and adverse-event reporting. Retailers should not place a general wellness product beside licensed medicines in a way that blurs their different evidentiary standards.
Consumers can protect themselves by bringing the exact label—not only the brand name—to a pharmacist or clinician. They should be wary of testimonials presented as trials and of bundles whose cost depends on subscription renewal. New jaundice, dark urine or severe abdominal symptoms after starting a supplement warrant prompt medical advice.
Menopause is not a marketing niche; it is a health transition with effects that can disrupt sleep, work, relationships and wellbeing. Women need affordable choices supported by transparent evidence. The new analysis is most useful not as a verdict on every bottle, but as a demand that sellers prove what their confident labels encourage customers to believe.
Join the discussion